Advisory Research’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Advisory Research’s Portfolio TVTY Stock Details TVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,457	Closed	-$272K	–	457
2022 Q1	$272K	Buy	+8,457	New	+$229K	0.02%	314
2018 Q1	–	Sell	-37,505	Closed	-$1.37M	–	435
2017 Q4	$1.37M	Sell	37,505 -37,218	-50%	-$1.41M	0.02%	253
2017 Q3	$3.05M	Buy	74,723 +8,860	+13%	+$343K	0.05%	181
2017 Q2	$2.63M	Buy	+65,863	New	+$2.2M	0.04%	195

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Advisory Research's TVTY Position: Q2 2022 in Review

Advisory Research sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 8,457 shares — an estimated $272K sold.

Advisory Research first reported a position in TVTY in Q2 2017 and held it in 4 quarters. The position peaked at $3.05M in Q3 2017. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

Advisory Research reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Advisory Research sold 8,457 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $272K.
Advisory Research first reported a position in Tivity Health, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
Advisory Research's Tivity Health, Inc. Common Stock position peaked at $3.05M in Q3 2017.
4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.